Bioinformatic description of immunotherapy targets for pediatric T-cell leukemia and the impact of normal gene sets used for comparison

Frontiers in Oncology

Volumn 4 JUN, Issue , 2014, Pages

  Orentas, Rimas J ^a   Nordlund, Jessica ^b   He, Jianbin ^a   Sindiri, Sivasish ^a   Mackall, Crystal ^a   Fry, Terry J ^a   Khan, Javed ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Adoptive immunotherapy; Antibody therapy; Chimeric antigen receptors; HHIP; Immunotherapy; Pediatric leukemia; T ALL; TALLA 1

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD1 ANTIGEN; CD1B ANTIGEN; CD28 ANTIGEN; CD37 ANTIGEN; CD52 ANTIGEN; CD69 ANTIGEN; CD98 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 3; L SELECTIN; LEUKEMIA ANTIGEN; LYSOPHOSPHATIDIC ACID RECEPTOR; PROSTAGLANDIN E RECEPTOR 4; SONIC HEDGEHOG PROTEIN; T CELL ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; T LYMPHOCYTE RECEPTOR; T6 ANTIGEN; THYROTROPIN RECEPTOR; UNCLASSIFIED DRUG; ZINC TRANSPORTER;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILDHOOD LEUKEMIA; GENE EXPRESSION; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOTHERAPY; INFLAMMATION; LYMPHOCYTE; METABOLISM; NUCLEOTIDE SEQUENCE; T CELL LEUKEMIA; X CHROMOSOME;

EID: 84904645405     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00134     Document Type: Article

References (70)

1. So CWE. An overview: from discovery of candidate mutations to disease modeling and transformation mechanisms of acute leukemia. In: So CWE, editor. Leukemia: Methods and Protocols. New York: Humana Press (2008). p. 1-5. doi: 10.1007/978-1-59745-418-6_1
2. Lee DW, Barrett DM, Mackall C, Orentas R, Grupp SA. The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer. Clin Cancer Res (2012) 18(10):2780-90. doi:10.1158/1078-0432.CCR-11-1920
3. Orentas RJ, Lee DW, Mackall C. Immunotherapy targets in pediatric cancer. Front Oncol (2012) 2:3. doi:10.3389/fonc.2012.00003
4. Orentas RJ, Yang JJ, Wen X, Wei JS, Mackall CL, Khan J. Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers. Front Oncol (2012) 2:194. doi:10.3389/fonc.2012.00194
5. Pui CH, Behm FG, Crist WM. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood (1993) 82(2):343-62.
6. Reinherz EL, Kung PC, Goldstein G, Levey RH, Schlossman SF. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A (1980) 77(3):1588-92. doi:10.1073/pnas.77.3.1588
7. Crist WM, Shuster JJ, Falletta J, Pullen DJ, Berard CW, Vietti TJ, et al. Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group Study. Blood (1988) 72(6):1891-7.
8. Wada H, Masuda K, Satoh R, Kakugawa K, Ikawa T, Katsura Y, et al. Adult T-cell progenitors retain myeloid potential. Nature (2008) 452(7188):768-72. doi:10.1038/nature06839
9. Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 481(7380):157-63. doi:10.1038/nature10725
10. Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood (1995) 85(5):1151-68.
11. Nordlund J, Backlin CL, Wahlberg P, Busche S, Berglund EC, Eloranta ML, et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol (2013) 14(9):r105. doi:10.1186/gb-2013-14-9-r105
12. Schmiegelow K, Forestier E, Hellebostad M, Heyman M, Kristinsson J, Soderhall S, et al. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia (2010) 24(2):345-54. doi:10.1038/leu.2009.251
13. Glaab E, Garibaldi JM, Krasnogor N. ArrayMining: a modular web-application for microarray analysis combining ensemble and consensus methods with cross-study normalization. BMC Bioinformatics (2009) 10:358. doi:10.1186/1471-2105-10-358
14. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 19(2):185-93. doi:10.1093/bioinformatics/19.2.185
15. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res (2003) 31(4):e15. doi:10.1093/nar/gng015
16. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 4(2):249-64. doi:10.1093/biostatistics/4.2.249
17. Liu MJ, Bao S, Galvez-Peralta M, Pyle CJ, Rudawsky AC, Pavlovicz RE, et al. ZIP8 regulates host defense through zinc-mediated inhibition of NF-kappaB. Cell Rep (2013) 3(2):386-400. doi:10.1016/j.celrep.2013.01.009
18. Martin F, Roth DM, Jans DA, Pouton CW, Partridge LJ, Monk PN, et al. Tetraspanins in viral infections: a fundamental role in viral biology? J Virol (2005) 79(17):10839-51. doi:10.1128/JVI.79.17.10839-10851.2005
19. Wright MD, Moseley GW, van Spriel AB. Tetraspanin microdomains in immune cell signalling and malignant disease. Tissue Antigens (2004) 64(5):533-42. doi:10.1111/j.1399-0039.2004.00321.x
20. Palomba ML, Younes A. In the spotlight: a novel CD37 antibody-drug conjugate. Blood (2013) 122(20):3397-8. doi:10.1182/blood-2013-09-526384
21. Sun X, Cheng G, Hao M, Zheng J, Zhou X, Zhang J, et al. CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev (2010) 29(4):709-22. doi:10.1007/s10555-010-9256-x
22. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer (2004) 4(7):540-50. doi:10.1038/nrc1388
23. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 410(6824):50-6. doi:10.1038/35065016
24. Yue J, Pan Y, Sun L, Zhang K, Liu J, Lu L, et al. The unique disulfide bond-stabilized W1 beta4-beta1 loop in the alpha4 beta-propeller domain regulates integrin alpha4beta7 affinity and signaling. J Biol Chem (2013) 288(20):14228-37. doi:10.1074/jbc.M113.462630
25. Ko SY, Park CJ, Park SH, Cho YU, Jang S, Seo EJ, et al. High CXCR4 and low VLA-4 expression predicts poor survival in adults with acute lymphoblastic leukemia. Leuk Res (2014) 38(1):65-70. doi:10.1016/j.leukres.2013.10.016
26. Burgess M, Gill D, Singhania R, Cheung C, Chambers L, Renyolds BA, et al. CD62L as a therapeutic target in chronic lymphocytic leukemia. Clin Cancer Res (2013) 19(20):5675-85. doi:10.1158/1078-0432.CCR-13-1037
27. Hamann J, Montgomery KT, Lau S, Kucherlapati R, van Lier RA. AICL: a new activation-induced antigen encoded by the human NK gene complex. Immunogenetics (1997) 45(5):295-300. doi:10.1007/s002510050208
28. Del Poeta G, Del Principe MI, Zucchetto A, Luciano F, Buccisano F, Rossi FM, et al. CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study. Haematologica (2012) 97(2):279-87. doi:10.3324/haematol.2011.052829
29. Liu G, Lu S, Wang X, Page ST, Higano CS, Plymate SR, et al. Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis. J Clin Invest (2013) 123(10):4410-22. doi:10.1172/JCI69369
30. Hosen N, Park CY, Tatsumi N, Oji Y, Sugiyama H, Gramatzki M, et al. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia. Proc Natl Acad Sci U S A (2007) 104(26):11008-13. doi:10.1073/pnas.0704271104
31. Staudinger M, Humpe A, Gramatzki M. Strategies for purging CD96 stem cells in vitro and in vivo: new avenues for autologous stem cell transplantation in acute myeloid leukemia. Oncoimmunology (2013) 2(6):e24500. doi:10.4161/onci.24500
32. Faure GC, Amsellem S, Arnoulet C, Bardet V, Campos L, De Carvalho-Bittencourt M, et al. Mutual benefits of B-ALL and HLDA/HCDM HLDA 9th Barcelona 2010. Immunol Lett (2011) 134(2):145-9. doi:10.1016/j.imlet.2010.10.008
33. Kaufmann D, Gruener S, Braun F, Stark M, Griesser J, Hoffmeyer S, et al. EVI2B, a gene lying in an intron of the neurofibromatosis type 1 (NF1) gene, is as the NF1 gene involved in differentiation of melanocytes and keratinocytes and is overexpressed in cells derived from NF1 neurofibromas. DNA Cell Biol (1999) 18(5):345-56. doi:10.1089/104454999315240
34. Wang W, Yang Y, Li L, Shi Y. Synleurin, a novel leucine-rich repeat protein that increases the intensity of pleiotropic cytokine responses. Biochem Biophys Res Commun (2003) 305(4):981-8. doi:10.1016/S0006-291X(03)00876-3
35. Dey I, Beck PL, Chadee K. Lymphocytic colitis is associated with increased pro-inflammatory cytokine profile and up regulation of prostaglandin receptor EP4. PLoS One (2013) 8(4):e61891. doi:10.1371/journal.pone.0061891
36. Draber P, Stepanek O, Hrdinka M, Drobek A, Chmatal L, Mala L, et al. LST1/A is a myeloid leukocyte-specific transmembrane adaptor protein recruiting protein tyrosine phosphatases SHP-1 and SHP-2 to the plasma membrane. J Biol Chem (2012) 287(27):22812-21. doi:10.1074/jbc.M112.339143
37. Mutis T, Blokland E, Kester M, Schrama E, Goulmy E. Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation. Blood (2002) 100(2):547-52. doi:10.1182/blood-2002-01-0024
38. Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA, et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci U S A (2003) 100(5):2742-7. doi:10.1073/pnas.0530192100
39. Lehner M, Gotz G, Proff J, Schaft N, Dorrie J, Full F, et al. Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection. PLoS One (2012) 7(2):e31210. doi:10.1371/journal.pone.0031210
40. Yan Q, Malashkevich VN, Fedorov A, Fedorov E, Cao E, Lary JW, et al. Structure of CD84 provides insight into SLAM family function. Proc Natl Acad Sci U S A (2007) 104(25):10583-8. doi:10.1073/pnas.0703893104
41. Dworzak MN, Froschl G, Printz D, Zen LD, Gaipa G, Ratei R, et al. CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease. Leukemia (2004) 18(4):703-8. doi:10.1038/sj.leu.2403303
42. Adams EJ. Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them. Curr Opin Immunol (2014) 26C:1-6. doi:10.1016/j.coi.2013.09.005
43. Van Rhijn I, Kasmar A, de Jong A, Gras S, Bhati M, Doorenspleet ME, et al. A conserved human T cell population targets mycobacterial antigens presented by CD1b. Nat Immunol (2013) 14(7):706-13. doi:10.1038/ni.2630
44. Gutierrez A, Sanda T, Ma W, Zhang J, Grebliunaite R, Dahlberg S, et al. Inactivation of LEF1 in T-cell acute lymphoblastic leukemia. Blood (2010) 115(14):2845-51. doi:10.1182/blood-2009-07-234377
45. Molica S, Dattilo A, Mannella A, Levato D. Intercellular adhesion molecules (ICAMs) 2 and 3 are frequently expressed in B cell chronic lymphocytic leukemia. Leukemia (1996) 10(5):907-8.
46. Cordell JL, Pulford K, Turley H, Jones M, Micklem K, Doussis IA, et al. Cellular distribution of human leucocyte adhesion molecule ICAM-3. J Clin Pathol (1994) 47(2):143-7. doi:10.1136/jcp.47.2.143
47. Maxwell CA, Benitez J, Gomez-Baldo L, Osorio A, Bonifaci N, Fernandez-Ramires R, et al. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol (2011) 9(11):e1001199. doi:10.1371/journal.pbio.1001199
48. Spranger S, Jeremias I, Wilde S, Leisegang M, Starck L, Mosetter B, et al. TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo. Blood (2012) 119(15):3440-9. doi:10.1182/blood-2011-06-357939
49. Herzog H, Darby K, Hort YJ, Shine J. Intron 17 of the human retinoblastoma susceptibility gene encodes an actively transcribed G protein-coupled receptor gene. Genome Res (1996) 6(9):858-61. doi:10.1101/gr.6.9.858
50. Mills GB, Moolenaar WH. The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer (2003) 3(8):582-91. doi:10.1038/nrc1143
51. Park CY, Hoover PJ, Mullins FM, Bachhawat P, Covington ED, Raunser S, et al. STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. Cell (2009) 136(5):876-90. doi:10.1016/j.cell.2009.02.014
52. Bosanac I, Maun HR, Scales SJ, Wen X, Lingel A, Bazan JF, et al. The structure of SHH in complex with HHIP reveals a recognition role for the Shh pseudo active site in signaling. Nat Struct Mol Biol (2009) 16(7):691-7. doi:10.1038/nsmb.1632
53. Kobune M, Iyama S, Kikuchi S, Horiguchi H, Sato T, Murase K, et al. Stromal cells expressing hedgehog-interacting protein regulate the proliferation of myeloid neoplasms. Blood Cancer J (2012) 2:e87. doi:10.1038/bcj.2012.36
54. Arturi F, Scarpelli D, Coco A, Sacco R, Bruno R, Filetti S, et al. Thyrotropin receptor mutations and thyroid hyperfunctioning adenomas ten years after their first discovery: unresolved questions. Thyroid (2003) 13(4):341-3. doi:10.1089/105072503321669811
55. Celano M, Sponziello M, Tallini G, Maggisano V, Bruno R, Dima M, et al. Increased expression of pro-angiogenic factors and vascularization in thyroid hyperfunctioning adenomas with and without TSH receptor activating mutations. Endocrine (2013) 43(1):147-53. doi:10.1007/s12020-012-9747-3
56. Loh ML, Zhang J, Harvey RC, Roberts K, Payne-Turner D, Kang H, et al. Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project. Blood (2013) 121(3):485-8. doi:10.1182/blood-2012-04-422691
57. Mullighan CG, Collins-Underwood JR, Phillips LA, Loudin MG, Liu W, Zhang J, et al. Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet (2009) 41(11):1243-6. doi:10.1038/ng.469
58. Fujiwara S, Yamashita Y, Choi YL, Watanabe H, Kurashina K, Soda M, et al. Transforming activity of purinergic receptor P2Y, G protein coupled, 8 revealed by retroviral expression screening. Leuk Lymphoma (2007) 48(5):978-86. doi:10.1080/10428190701225882
59. Pang WW, Price EA, Sahoo D, Beerman I, Maloney WJ, Rossi DJ, et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A (2011) 108(50):20012-7. doi:10.1073/pnas.1116110108
60. Kemppinen AK, Kaprio J, Palotie A, Saarela J. Systematic review of genome-wide expression studies in multiple sclerosis. BMJ Open (2011) 1(1):e000053. doi:10.1136/bmjopen-2011-000053
61. Seon BK, Negoro S, Barcos MP. Monoclonal antibody that defines a unique human T-cell leukemia antigen. Proc Natl Acad Sci U S A (1983) 80(3):845-9. doi:10.1073/pnas.80.3.845
62. Seon BK, Negoro S, Barcos MP, Tebbi CK, Chervinsky D, Fukukawa T. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein. J Immunol (1984) 132(4):2089-95.
63. Hara H, Seon BK. Complete suppression of in vivo growth of human leukemia cells by specific immunotoxins: nude mouse models. Proc Natl Acad Sci U S A (1987) 84(10):3390-4. doi:10.1073/pnas.84.10.3390
64. Bassani S, Cingolani LA, Valnegri P, Folci A, Zapata J, Gianfelice A, et al. The X-linked intellectual disability protein TSPAN7 regulates excitatory synapse development and AMPAR trafficking. Neuron (2012) 73(6):1143-58. doi:10.1016/j.neuron.2012.01.021
65. Cantor JM, Ginsberg MH. CD98 at the crossroads of adaptive immunity and cancer. J Cell Sci (2012) 125(Pt 6):1373-82. doi:10.1242/jcs.096040
66. van der Welden VHJ, van Dongen JJM. MRD detection in acute lymphoblastic leukemia patients using Ig/TCR gene rearrangements as targets for real-time quantitative PCR. In: So CWE, editor. Leukemia: Methods and Protocols. New York: Humana Press (2008). p. 115-50. doi:10.1007/978-1-59745-418-6_7
67. Campana D, van Dongen JJ, Mehta A, Coustan-Smith E, Wolvers-Tettero IL, Ganeshaguru K, et al. Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia. Blood (1991) 77(7):1546-54.
68. Suzushima H, Hattori T, Asou N, Wang JX, Nishikawa K, Okubo T, et al. Discordant gene and surface expression of the T-cell receptor/CD3 complex in adult T-cell leukemia cells. Cancer Res (1991) 51(22):6084-8.
69. Campana D, Behm FG. Immunophenotyping of leukemia. J Immunol Methods (2000) 243(1-2):59-75. doi:10.1016/S0022-1759(00)00228-3
70. Kloss CC, Condomines M, Cartellieri M, Bachmann M, Sadelain M. Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells. Nat Biotechnol (2013) 31(1):71-5. doi:10.1038/nbt.2459